CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.

作者: I Haque , S Banerjee , A De , G Maity , S Sarkar

DOI: 10.1038/ONC.2014.250

关键词:

摘要: The matricellular protein CCN5/WISP-2 represents a promising target in triple-negative breast cancer (TNBC) because treatment or induced activation of CCN5 TNBC cells promotes cell growth arrest at the G0/G1 phase, reduces proliferation and delays tumor xenograft model. Our studies found that p27(Kip1) suppressor is upregulated relocalized to nucleus from cytoplasm by these two events (upregulation relocalization p27(Kip1)) are critical for CCN5-induced inhibition cells. In absence CCN5, resides mostly cytoplasm, which associated with aggressive nature Mechanistically, inhibits Skp2 expression, seems stabilize On other hand, also recruits FOXO3a mediate transcriptional regulation p27(Kip1). recruitment achieved induction its expression activity through shifting nucleus. data indicate blocks PI3K/AKT signaling dephosphorylate S318, S253 Thr32 nuclear FOXO3a. Moreover, α6β1 receptors diminishes action on Collectively, suggest effectively accumulation trafficking via regulation, thus, may have therapeutic potential kill TNBC.

参考文章(55)
Maria Letizia Motti, Daniela Califano, Giancarlo Troncone, Carmela De Marco, Ilenia Migliaccio, Emiliano Palmieri, Luciano Pezzullo, Lucio Palombini, Alfredo Fusco, Giuseppe Viglietto, Complex Regulation of the Cyclin-Dependent Kinase Inhibitor p27kip1 in Thyroid Cancer Cells by the PI3K/AKT Pathway: Regulation of p27kip1 Expression and Localization American Journal of Pathology. ,vol. 166, pp. 737- 749 ,(2005) , 10.1016/S0002-9440(10)62295-X
Stefanie S Jeffrey, Lucinei Roberto Oliveira, Alfredo Ribeiro-Silva, Stem cells in human breast cancer Histology and Histopathology. ,vol. 25, pp. 371- 385 ,(2010) , 10.14670/HH-25.371
Massimo Loda, Cristina Magi-Galluzzi, Michele Pagano, Barry Cukor, Molly Wanner, Blake Cady, Philip Lavin, Puay Tan, Giulio Draetta, Peter Worland, The Cell Cycle Inhibitor p27 Is an Independent Prognostic Marker in Small (T1a,b) Invasive Breast Carcinomas Cancer Research. ,vol. 57, pp. 1259- 1263 ,(1997)
J. Slingerland, M. Pagano, Regulation of the Cdk Inhibitor p27 and Its Deregulation in Cancer Journal of Cellular Physiology. ,vol. 183, pp. 10- 17 ,(2000) , 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I
Joanna Bloom, Michele Pagano, Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Seminars in Cancer Biology. ,vol. 13, pp. 41- 47 ,(2003) , 10.1016/S1044-579X(02)00098-6
K Polyak, J Y Kato, M J Solomon, C J Sherr, J Massague, J M Roberts, A Koff, p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes & Development. ,vol. 8, pp. 9- 22 ,(1994) , 10.1101/GAD.8.1.9
Jamison Nourse, Eduardo Firpo, W. Michael Flanagan, Steve Coats, Kornelia Polyak, Mong-Hong Lee, Joan Massague, Gerald R. Crabtree, James M. Roberts, Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature. ,vol. 372, pp. 570- 573 ,(1994) , 10.1038/372570A0
Giuseppe Viglietto, Maria Letizia Motti, Paola Bruni, Rosa Marina Melillo, Amelia D'Alessio, Daniela Califano, Floriana Vinci, Gennaro Chiappetta, Philip Tsichlis, Alfonso Bellacosa, Alfredo Fusco, Massimo Santoro, Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 Kip1 by PKB/Akt-mediated phosphorylation in breast cancer Nature Medicine. ,vol. 8, pp. 1136- 1144 ,(2002) , 10.1038/NM762